Cancer Biology & Therapy, Volume 22, Issue 1 (2021)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Cancer Biology & Therapy, Volume 22, Issue 1 (2021)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Volume 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2011 Vol 10, 2010 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Bedside-to-Bench Report

The efficacy of lorlatinib in a lung adenocarcinoma patient with a novel ALK G1202L mutation: a case report
Zhaoting Meng, Ting Li, Pei Wang, Analyn Lizaso & Dingzhi Huang
Pages: 1-4
Published online: 30 Dec 2020
AbstractforThe efficacy of lorlatinib in a lung adenocarcinoma patient with a novel ALK G1202L mutation: a case report | Full Text | References | PDF (2.6 MB) | EPUB
  • 842 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway
Jianxin Xu, Xuejiao Fang, Luye Long, Sixuan Wang, Shihan Qian & Jianxin Lyu
Pages: 5-11
Published online: 13 Dec 2020
AbstractforHMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway | Full Text | References | PDF (3.8 MB) | EPUB | Supplemental
  • 2282 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Targeted drug delivery using an aptamer against shared tumor-specific peptide antigen of MAGE-A3
Chin-Yu Wang, Bai-Ling Lin & Chung-Hsuan Chen
Pages: 12-18
Published online: 29 Nov 2020
AbstractforTargeted drug delivery using an aptamer against shared tumor-specific peptide antigen of MAGE-A3 | Full Text | References | PDF (2.9 MB) | EPUB | Supplemental
  • 955 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
MAP17 contributes to non-small cell lung cancer progression via suppressing miR-27a-3p expression and p38 signaling pathway
Qian Liang & Huan Zhang
Pages: 19-29
Published online: 07 Dec 2020
AbstractforMAP17 contributes to non-small cell lung cancer progression via suppressing miR-27a-3p expression and p38 signaling pathway | Full Text | References | PDF (9.4 MB) | EPUB
  • 753 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
CXCL6 regulates cell permeability, proliferation, and apoptosis after ischemia–reperfusion injury by modulating Sirt3 expression via AKT/FOXO3a activation
Xiaolin Wang, Yuanqiang Dai, Xiaoxiu Zhang, Ke Pan, Yu Deng, Jiafeng Wang & Tao Xu
Pages: 30-39
Published online: 26 Nov 2020
AbstractforCXCL6 regulates cell permeability, proliferation, and apoptosis after ischemia–reperfusion injury by modulating Sirt3 expression via AKT/FOXO3a activation | Full Text | References | PDF (2.3 MB) | EPUB
  • 1583 Views
  • 19 CrossRef citations
  • 0Altmetric
Free Access
Article
The top 100 most-cited papers in long non-coding RNAs: a bibliometric study
Meng-Si Peng, Chang-Cheng Chen, Juan Wang, Yi-Li Zheng, Jia-Bao Guo, Ge Song & Xue-Qiang Wang
Pages: 40-54
Published online: 14 Dec 2020
AbstractforThe top 100 most-cited papers in long non-coding RNAs: a bibliometric study | Full Text | References | PDF (2 MB) | EPUB
  • 1425 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy
Mi Jeong Kim, Guo Chen, Gabriel L. Sica & Xingming Deng
Pages: 55-65
Published online: 18 Dec 2020
AbstractforEpigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy | Full Text | References | PDF (7.1 MB) | EPUB | Supplemental
  • 1382 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
JAK-STAT inhibitor as a potential therapeutic opportunity in AML patients resistant to cytarabine and epigenetic therapy
Govind Babu, Padmaparna Chaudhuri, Manoj Rajappa, Manjusha Biswas, Bipinesh Sansar, Chethan Rajegowda, Aneesha Radhakrishnan, Jayshree Advani, Biplab Tewary, Padhma Radhakrishnan, Saravanan Thiyagarajan, Aditi Chatterjee, Ram Shankar Upadhayaya & Pradip K Majumder
Pages: 66-78
Published online: 27 Dec 2020
AbstractforJAK-STAT inhibitor as a potential therapeutic opportunity in AML patients resistant to cytarabine and epigenetic therapy | Full Text | References | PDF (5.1 MB) | EPUB | Supplemental
  • 1371 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
The therapeutic potential of attenuated diphtheria toxin delivered by an adenovirus vector with survivin promoter on human lung cancer cells
Lvxia Dai, Xiaoping Yu, Sizhou Huang, Yanjuan Peng, Jianmin Liu, Tian Chen, Xin Wang, Qiaofeng Liu, Yanfeng Zhu, Dengbang Chen, Xiaohua Li, Yu Ou, Yi Zou, Qu Pan & Kang Cao
Pages: 79-87
Published online: 30 Dec 2020
AbstractforThe therapeutic potential of attenuated diphtheria toxin delivered by an adenovirus vector with survivin promoter on human lung cancer cells | Full Text | References | PDF (3.5 MB) | EPUB
  • 1147 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Mechanism investigation of Forsythoside A against esophageal squamous cell carcinoma in vitro and in vivo
Yingying Yang et al.
Article | Published online: 24 Jul 2024
Open Access
Association between the IL1B-511 C>T polymorphism and the risk of hematologic malignancies: data from a meta-analysis
Fabíola Silva Alves-Hanna et al.
Review Article | Published online: 22 Jul 2024
Open Access
Natural killer cell memory: challenges and opportunities for cancer immunotherapy
Yuhua Qu et al.
Review Article | Published online: 10 Jul 2024
Open Access
Jmjd2c maintains the ALDHbri+ cancer stemness with transcription factor SOX2 in lung squamous cell carcinoma
Min Wang et al.
Article | Published online: 8 Jul 2024
Open Access